Why the study?
The study was conducted to assess the relationship between serum glutamic oxaloacetic transaminase (SGOT) levels and clinical characteristics in acute myocardial infarction patients without prior liver disease.
Are elevated SGOT levels associated with specific clinical characteristics and severity of myocardial damage in AMI patients?
Population
120 AMI patients aged ≥18 years without prior liver disease
Comparison
SGOT levels >40 U/L vs normal levels
Design
Cross-sectional study
Authors
Loading...
Highlights prehospital delays in Central Indian ACS; leaves open targeted education and transport strategies for prospective evaluation.
Are elevated SGOT levels associated with specific clinical characteristics and severity of myocardial damage in AMI patients?
Elevated SGOT levels in AMI patients are significantly associated with STEMI, hypertension, and diabetes, highlighting its potential as a biomarker for severe myocardial injury.
Paladi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: